Results 91 to 100 of about 45,299 (154)

Impact of drug repurposing between 1985 and 2024 on pharmaceutical innovation. [PDF]

Commun Med (Lond)
Akodad S, Niu X, Secades B, Stevens H.
europepmc   +1 more source

FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints. [PDF]

iScience
Kumar H, Tsang SV, Lee MS, Huang YH, Choi J, Lotlikar SR, Song JY, Toh A, Choi YL, Brannan KW, Kim P.   +10 more
europepmc   +1 more source

A biology-based quality-diversity algorithm for drug repurposing in Alzheimer's disease using automated machine learning. [PDF]

BioData Min
Shao S, Ribeiro PH, Orlenko A, Cardone KM, Ramirez CM, Shen L, Ritchie MD, Moore JH.   +7 more
europepmc   +1 more source

Drug repurposing for Alzheimer's disease: a Delphi consensus and stakeholder consultation. [PDF]

Alzheimers Res Ther
Corbett A, Sultana J, Stych K, Mills R, Cummings JL, Williams G, Ismail Z, Soto-Martin M, Mintzer J, Gauthier S, Greig NH, Noble W, Killick R, Lai MKP, Routledge C, Walsh F, Fillit H, Aarsland D, Lane R, Mills K, Ballard C.   +20 more
europepmc   +1 more source

AI in drug repurposing for cancer therapies. [PDF]

Ann Med Surg (Lond)
Saddique MN, Abu Nahla U.
europepmc   +1 more source

Integrative Multi-Omics and Machine Learning Analysis Identifies Therapeutic Targets and Drug Repurposing Candidates for Alzheimer's Disease. [PDF]

Biomedicines
Xiao B, Chen YQ, Wang S.
europepmc   +1 more source

Benchmarking heterogeneous network-based methods for drug repurposing. [PDF]

NPJ Syst Biol Appl
Nguyen TT, Pawitan Y, Calza S, Vu TN.
europepmc   +1 more source

Drug Repurposing for Kala-Azar. [PDF]

Pharmaceutics
Arsić B, Ilić BS, Maier A, Hartung M, Janjić J, Milićević J, Baumbach J.   +6 more
europepmc   +1 more source